Filtros de búsqueda

Lista de obras de Francesco Sabbatino

A monocentric phase I study of vemurafenib plus cobimetinib plus PEG-interferon (VEMUPLINT) in advanced melanoma patients harboring the V600BRAF mutation

scientific article published on 06 January 2021

Abstract 4017: Anti-tumor activity of a BRAF inhibitor and IFNα combination in BRAF mutant melanoma

artículo científico publicado en 2016

Anti-proliferative and pro-apoptotic activity of GD2 ganglioside-specific monoclonal antibody 3F8 in human melanoma cells

artículo científico publicado en 2015

Antitumor Activity of BRAF Inhibitor and IFNα Combination in BRAF-Mutant Melanoma

artículo científico publicado en 2016

Can the "right" EGFR-specific mAb dramatically improve EGFR-targeted therapy?

artículo científico publicado en 2013

Detection of chondroitin sulfate proteoglycan 4 (CSPG4) in melanoma

scientific article published on 01 January 2014

Effect of p53 activity on the sensitivity of human glioblastoma cells to PARP-1 inhibitor in combination with topoisomerase I inhibitor or radiation

artículo científico publicado en 2014

Emerging BRAF inhibitors for melanoma.

artículo científico publicado en 2013

Erratum to: The Ability to Diagnose Intrahepatic Cholangiocarcinoma Definitively Using Novel Branched DNA-Enhanced Albumin RNA In Situ Hybridization Technology

artículo científico publicado en 2015

Erratum to: The Ability to Diagnose Intrahepatic Cholangiocarcinoma Definitively Using Novel Branched DNA-Enhanced Albumin RNA In Situ Hybridization Technology

artículo científico publicado en 2015

Evolution of studies of HLA class I antigen processing machinery (APM) components in malignant cells

artículo científico

Genetic evolution of T-cell resistance in the course of melanoma progression

artículo científico publicado en 2014

Grp94-specific monoclonal antibody to counteract BRAF inhibitor resistance in BRAFV600E melanoma.

artículo científico publicado en 2015

HLA class I downregulation is associated with enhanced NK-cell killing of melanoma cells with acquired drug resistance to BRAF inhibitors.

artículo científico publicado en 2015

Harnessing host innate immunity may combat acquired resistance to BRAFi

artículo científico publicado en 2014

Ipilimumab in the treatment of metastatic melanoma: management of adverse events.

artículo científico publicado en 2014

Melanoma and immunotherapy bridge 2015 : Naples, Italy. 1-5 December 2015

artículo científico publicado en 2016

Monoclonal antibody-based immunotherapy of ovarian cancer: targeting ovarian cancer cells with the B7-H3-specific mAb 376.96.

artículo científico publicado en 2013

Multidisciplinary approach to patient with malignant melanoma.

artículo científico publicado en 2013

Novel tumor antigen-specific monoclonal antibody-based immunotherapy to eradicate both differentiated cancer cells and cancer-initiating cells in solid tumors.

artículo científico publicado en 2014

PD-L1 and HLA Class I Antigen Expression and Clinical Course of the Disease in Intrahepatic Cholangiocarcinoma

artículo científico publicado en 2015

PDGFRα up-regulation mediated by sonic hedgehog pathway activation leads to BRAF inhibitor resistance in melanoma cells with BRAF mutation

artículo científico publicado en 2014

Radiological and surgical implications of neoadjuvant treatment with FOLFIRINOX for locally advanced and borderline resectable pancreatic cancer

artículo científico publicado en 2015

The Ability to Diagnose Intrahepatic Cholangiocarcinoma Definitively Using Novel Branched DNA-Enhanced Albumin RNA In Situ Hybridization Technology

artículo científico publicado en 2014

Tissue Micro Arrays for immunohistochemical detection of inflammatory infiltrates in renal cell carcinoma

artículo científico publicado en 2014

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda